DEA Places Brivaracetam Into Schedule V
The Drug Enforcement Administration placed brivaracetam into Schedule V of the Controlled Substances Act, in an interim final rule (here). Effective May 12, brivaracetam will be subject to new registration, labeling, recordkeeping, and import and export requirements. Comments on the listing are due June 13, it said.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(Federal Register 05/12/16)